TRPM8 antagonists

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9585875
SERIAL NO

14366796

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to compounds acting as selective antagonists of Transient Receptor Potential cation channel subfamily M member 8 (TRPM8), and having formula (I). Said compounds are useful in the treatment of diseases associated with activity of TRPM8 such as pain, inflammation, ischaemia, neurodegeneration, stroke, psychiatric disorders, itch, irritable bowel diseases, cold induced and/or exhacerbated respiratory disorders and urological disorders.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • DOMPÉ FARMACEUTICI S.P.A.;DOMPÉ S.P.A.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Aramini, Andrea L'Aquila, IT 30 42
Bianchini, Gianluca L'Aquila, IT 19 12
Bovolenta, Silvia Via Olgettina, IT 5 10
Brandolini, Laura L'Aquiula, IT 15 22
Colagioia, Sandro L'Aquila, IT 2 7
Liberati, Chiara Via Olgettina, IT 9 10
Moriconi, Alessio L'Aquila, IT 12 26

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 7, 2024
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 7, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00